Invesaro

Stocks Health care EMBC

NASDAQ · Health care

Embecta Corp. (EMBC)

Embecta Corp. brought in $1B of revenue over the twelve months to June 30, 2026, down 7.6% from a year earlier. Net income was $87.5M, a net margin of 8.6%. Operating cash flow minus capital spending left $182.4M of free cash flow in fiscal 2025. At June 30, 2026 it held $214.7M in cash against $1.5B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.

Price
$5.90
+4.98% on the day · September 25, 2026
52-week range $2.77 to $14.91
Market cap
$334.3M
Revenue (last 12 months)
$1B
-7.6% year on year
Net margin
8.6%
P/E
3.6
on FY2025 diluted EPS

What Embecta Corp. does

Embecta Corp. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker EMBC.

Revenue and profit by year

Revenue
FY20: $1.1B $1.1B FY20FY22: $1.2B $1.2B FY22FY22: $1.1B $1.1B FY22FY23: $1.1B $1.1B FY23FY24: $1.1B $1.1B FY24FY25: $1.1B $1.1B FY25
Net income
FY20: $427.6M $427.6M FY20FY22: $414.8M $414.8M FY22FY22: $223.6M $223.6M FY22FY23: $70.4M $70.4M FY23FY24: $78.3M $78.3M FY24FY25: $95.4M $95.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.1B$242.1M$95.4M$1.62$182.4M
2024$1.1B$166.8M$78.3M$1.34$19.9M
2023$1.1B$221.5M$70.4M$1.22$41.2M
2022$1.1B$309.6M$223.6M$3.89$388.6M
2022$1.2B$492M$414.8M$7.28$419.5M
2020$1.1B$486.5M$427.6M$7.50$456.6M

Latest SEC filings

What Embecta Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
  2. August 7, 2026
  3. August 7, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. August 7, 2026
  5. July 31, 2026
  6. July 8, 2026
  7. May 27, 2026
  8. May 22, 2026
  9. May 15, 2026
  10. May 5, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 8, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about EMBC

What does Embecta Corp. do?

Embecta Corp. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker EMBC.

Is Embecta Corp. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $87.5M on revenue of $1B, a net margin of 8.6%.

How much revenue does Embecta Corp. make?

Over the twelve months to June 30, 2026 Embecta Corp. reported revenue of $1B. That is 7.6% less than a year earlier.

When did Embecta Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 8, 2026.

Similar companies

Follow EMBC

Get an email when Embecta Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow EMBC: get an email when it files

Where the numbers come from

Financial figures are the values Embecta Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.